US$ 23.69
tesamorelin with retatrutide (10mg) – Vitanx Research Retatrutide vs Tesamorelin for fat
Description
Weight Loss In both trials, a marked dose-dependent WL was observed
In Phase 3 trials, diarrhoea affected up to 34.1% of people taking retatrutide, compared with 13.5% on placebo
Values from cited NEJM 2023 phase 2 trial and Urva 2022 phase 1b PK study
That note gives the billing team a clear path

This is also what side effects, such as hair loss, weakness and fatigue can come into play

doi: 10.4103/2230-8210.126572 156 DingHWangMZhangJWanCHuangZLiuLet al
